Individuals with obesity have an increased risk for heart disease and diabetes. There are
current drugs on the market that target the hormone, Glucagon like peptide-1 (GLP-1) to treat
diabetes. The investigators want to determine if targeting this hormone will also help people
with high cholesterol and triglycerides. In this study, the investigators are looking at the
role of GLP-1 in healthy subjects and subjects that have had bariatric surgery.